153
Participants
Start Date
June 24, 2015
Primary Completion Date
March 26, 2022
Study Completion Date
March 26, 2022
Denosumab
Subcutaneous (SC) injection.
Research Site, Budapest
Research Site, Brussels
Research Site, Sofia
Research Site, Sofia
Research Site, Westmead
Research Site, Leuven
Research Site, Subiaco
Research Site, Ghent
Research Site, Varna
Research Site, Wilmington
Research Site, Baltimore
Research Site, Getafe
Research Site, Decatur
Research Site, Toulouse
Research Site, Bordeaux
Research Site, Verona
Research Site, Nashville
Research Site, Saint-Priest-en-Jarez
Research Site, Valencia
Research Site, Indianapolis
Research Site, Cologne
Research Site, Iowa City
Research Site, Omaha
Research Site, Paris
Research Site, Paris
Research Site, Houston
Research Site, Aurora
Research Site, Los Angeles
Research Site, Torrance
Research Site, New Haven
Research Site, Boston
Research Site, Ottawa
Research Site, Toronto
Research Site, Montreal
Research Site, Hradec Králové
Research Site, Pardubice
Research Site, Pilsen
Research Site, Prague
Research Site, Zlín
Research Site, Roma
Research Site, Bialystok
Research Site, Lodz
Research Site, Rzeszów
Research Site, Warsaw
Research Site, Esplugues de Llobregat
Research Site, Birmingham
Research Site, Bristol
Research Site, Glasgow
Research Site, Sheffield
Lead Sponsor
Amgen
INDUSTRY